Associate Professor
Baylor College of Medicine
Houston, TX, US
Laser Surgery Center
Baylor College of Medicine Department of Dermatology
Baylor College of Medicine Aesthetics


MD from University Of Missouri - Kansas City
Internship at Baylor College of Medicine
Internal Medicine
Residency at Medical College of Wisconsin
Fellowship at Harvard Medical College
Laser Dermatology


American Board of Dermatology

Honors & Awards

That's the way!
An award given by BCM in recognition of exceptional patient service due to feedback from patients.
Texas Super Doctors: 2007, 2011, 2012, 2013, 2014, 2015
NASA preferred provider
H-Tex Top Doctor: 2007, 2008, 2009
Houston’s Best Physicians: 2008
Top Dermatologist: 2009
Baylor College of Medicine Best Suggestion Contest Winner (4 times between 2007-2012)
Best Research Poster Award
"Prospective randomized double blinded placebo controlled trial evaluating the effectiveness of Auriderm XO in preventing erythema & bruising after Pulsed Dye Laser treatment of the skin."
BCM Physician Top Performer in Patient Satisfaction
Given to physicians 2 standard deviations above mean satisfaction score from Press Ganey patient surveys

Professional Interests

  • Laser treatment of the skin
  • Botox injection
  • Hyperhidrosis treatment
  • Cool sculpting for fat removal
  • General Dermatology

Selected Publications


American Academy of Dermatology
American Society for Laser Medicine and Surgery


Prospective placebo controlled trial evaluating the 1450 nm Diode laser in the treatment of Seborrheic Dermatitis
American Society for Laser Medicine & Surgery 2005
Primary investigator
A randomized, double-blind, placebo controlled study evaluating the s-caine peel (lidocaine 7% and tetracaine 7% cream) for induction of local dermal anesthesia for pulsed dye laser therapy in adult subjects
Zars Pharmaceuticals 2003-2004
Primary investigator
A phase iii, multicenter, randomized, double blind, active and vehicle-controlled study of the safety and efficacy of velac gel for the treatment of acne vulgaris
Connetics Corporation 2003-2004
Phase iiib, open-label effectiveness and safety study of imiquimod 5% topical cream in the treatment of actinic keratosis
3M Corporation 2003-2004